about
Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodentsMolecular mechanisms of maternal cannabis and cigarette use on human neurodevelopmentEmerging drugs of abuse: current perspectives on synthetic cannabinoidsThe role of sex steroid hormones, cytokines and the endocannabinoid system in female fertilityWork-up of stillbirth: a review of the evidenceDevelopmental consequences of fetal exposure to drugs: what we know and what we still must learnIntimate partner violence, substance use, and adverse neonatal outcomes among urban women.Reducing low birth weight: prioritizing action to address modifiable risk factors.Retrospective analysis of the diagnostic yield of newborn drug testing.Approach to cannabis use disorder in primary care: focus on youth and other high-risk users.What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?It's not your mother's marijuana: effects on maternal-fetal health and the developing child.New vistas on cannabis use disorder.Cost benefit analysis of two policy options for cannabis: status quo and legalisation.The effects of prenatal cannabis exposure on fetal development and pregnancy outcomes: a protocol.Drug transfer and metabolism by the human placenta.Stillbirth: a review.Prenatal hazardous substance use and adverse birth outcomes.Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).Targeting the endocannabinoid system in treating brain disorders.Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokersCannabis and neurodevelopment: implications for psychiatric disorders.During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.Illicit drug use and adverse birth outcomes: is it drugs or context?Illicit substance use in pregnancy - a review.Urinary concentrations of PAH and VOC metabolites in marijuana users.Synthetic cannabinoids and potential reproductive consequences.Frequency and risk factors for the birth of small-for-gestational-age newborns in a public maternity hospital.Association between stillbirth and illicit drug use and smoking during pregnancy.Clinical interventions for women with schizophrenia: pregnancy.Cannabis, the pregnant woman and her child: weeding out the myths.Marijuana Use in Pregnancy: Concerns in an Evolving Era.A Case Report of Cannabis Induced Hemoptysis.Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse.A descriptive regional study of drug and alcohol use in pregnant women using results from urine drug testing by liquid chromatography-tandem mass spectrometry.Maternal psychological distress during pregnancy does not increase the risk for adverse birth outcomes.Association between marijuana use and adverse obstetrical and neonatal outcomes.Prevalence and risk factors for cannabis use in low-income pregnant women in São Paulo, Brazil.Management of cannabis use during pregnancy: an assessment of healthcare professionals' practices.Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia.
P2860
Q24613945-F2E805EF-C990-4776-AFA1-C388360D7444Q24633636-6788519F-1DB5-46F9-90CB-46FC37811E1FQ26778885-0BEB52F8-4A62-4BB2-ADDF-2E186DF735B7Q28303095-AF1E127D-1D5C-4FAA-8737-B18ADAD21169Q28389394-7D0B2BB2-BBB8-4A84-B1EE-D22EE056F3DBQ30395013-37D8164A-FE19-4F6C-8FFB-4861B75EA754Q30411587-6DA4C575-72CC-462A-9DE6-2693927C373CQ33614598-9AC97CD0-F041-4338-BB9B-20A012F7E969Q34012137-B0DB90D2-C5F8-4EF6-8FC2-6C198BFA94E5Q34173037-57DC1FA5-6514-438F-B4C9-22C9097F96E6Q34442084-419A0881-674F-4BCE-A902-86F13C863B35Q34625334-3BE829EC-1A46-4F8E-BD0D-842FBC8B8E88Q34681365-62CE7BF0-1764-4E3A-8600-C78C0BB6E31DQ35155226-43CBE755-7581-455A-AB1E-6EE20BFED550Q35179954-3A0015D9-DB57-48E0-BDF5-98D6BA6EE7D5Q35788063-8541157D-5694-4C2E-8A5E-CFA45EE21608Q35931983-8E5A75C4-6F32-4068-9763-86A2DF818DD1Q36098900-412B4617-FCD3-4C88-ACFC-CE954C6FD638Q36291274-EAE9575F-A1B8-44E7-ADD6-7CA78010AAEDQ36425999-9F82EA13-02A5-4087-8C1D-CE01DC37A62FQ36463925-48D9D2C3-9A83-4128-AD2D-69DDD224BFA9Q36511000-6287D1CB-35A8-4C0F-B1D6-1F0B1B31FFEFQ36587829-D3EBFBDB-2E46-4AE1-8BA3-9AD325C83162Q36985301-0739FE5A-6CD5-4BC1-B9DB-C1B0BECAF8FFQ37185873-C6954FAD-1A31-405D-B34E-8A9E694CF203Q37258411-3E40AF34-1AC6-4046-868D-BEE31B04B767Q37297158-322F3550-D7F2-441F-A3C3-F26BC7F32D7FQ37585569-127B07EA-5B76-4B65-9823-5CAB96505EF5Q37597293-5CBD07DE-2D3F-480F-8F25-DD53B8B8CD61Q38020196-1E9E2EAC-6979-41FB-B31F-AD078B66494BQ38181303-86F6BD45-12F5-44AF-BF4F-9BB24E144679Q38789335-A5C2CAE2-A188-4BA4-B61C-31F70E7B4CDAQ38797800-6147CC66-4B89-485C-B335-968F1BC226A4Q39990354-1107F108-8E77-41B8-901B-90311ED693FAQ40061288-E2DC6229-84A0-483C-A2E7-A05C5C34A86FQ40369207-F2D00256-A8DC-47C5-8686-6755A4F8880FQ41325416-C183E22C-492F-4965-B828-BE7A419E8BBBQ41740361-FA6F5FBE-EC05-4CA1-B547-39FC8CB0C82AQ44766715-17B17089-BA70-42C8-9AEB-D4524CAB8381Q44999834-F3FF36A5-57D7-4FF0-9359-B5DFAE47E96A
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Maternal use of cannabis and pregnancy outcome.
@en
Maternal use of cannabis and pregnancy outcome.
@nl
type
label
Maternal use of cannabis and pregnancy outcome.
@en
Maternal use of cannabis and pregnancy outcome.
@nl
prefLabel
Maternal use of cannabis and pregnancy outcome.
@en
Maternal use of cannabis and pregnancy outcome.
@nl
P50
P1476
Maternal use of cannabis and pregnancy outcome
@en
P2093
ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood
P2860
P356
10.1111/J.1471-0528.2002.01020.X
P577
2002-01-01T00:00:00Z